{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:45:04Z","timestamp":1786715104028,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0301-4738.178142","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T02:05:18Z","timestamp":1457316318000},"page":"14","source":"Crossref","is-referenced-by-count":20,"title":["Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines"],"prefix":"10.4103","volume":"64","author":[{"given":"Taraprasad","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Aurora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anantharaman","family":"Giridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Ramasamay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.178142-1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"key-10.4103\/0301-4738.178142-2","unstructured":"World Health Organization. Global Health Risks. Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009."},{"key":"key-10.4103\/0301-4738.178142-3","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"key-10.4103\/0301-4738.178142-4","unstructured":"World Health Organization. Global Status Report on Non Communicable Diseases 2010. Geneva: World Health Organization; 2011."},{"key":"key-10.4103\/0301-4738.178142-5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"key-10.4103\/0301-4738.178142-6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/bjo.83.8.937","article-title":"Population based assessment of diabetic retinopathy in an urban population in Southern India","author":"Dandona","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.178142-7","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1167\/iovs.05-0019","article-title":"Prevalence of diabetic retinopathy in urban India: The Chennai urban rural epidemiology study (CURES) eye study, I","author":"Rema","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.178142-8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/bjo.86.9.1014","article-title":"Diabetic retinopathy among self reported diabetics in Southern India: A population based assessment","author":"Narendran","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.178142-9","first-page":"16","article-title":"Prevalence of diabetic retinopathy in type 2 diabetes in relation to risk factors: Hospital based study","author":"Agarwal","year":"2003","journal-title":"Int J Diabetes Dev Ctries"},{"key":"key-10.4103\/0301-4738.178142-10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.178142-11","first-page":"1796","article-title":"Early treatment diabetic retinopathy study report number 1.Early treatment diabetic retinopathy study research group","author":"Photocoagulation","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.178142-12","first-page":"761","article-title":"Early treatment diabetic retinopathy study report number 2.Early treatment diabetic retinopathy study research group","author":"Treatment","year":"1987","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(99)00033-1","article-title":"Patterns of diabetic macular edema with optical coherence tomography","author":"Otani","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.178142-14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.178142-15","doi-asserted-by":"crossref","unstructured":"Das T, Simanjuntak G, Sumasri K. Optical coherence tomography titrated photocoagulation in diabetic clinicllay significant macular edema. In: Binder S, editor. The Macula. Berlin: Spinger-Verlag; 2004. p. 185-94.","DOI":"10.1007\/978-3-7091-7985-7_21"},{"key":"key-10.4103\/0301-4738.178142-16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2008.10.001","article-title":"Diabetic macular edema: Pathogenesis and treatment","author":"Bhagat","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/0301-4738.178142-17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2011.02.045","article-title":"A phase 2\/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema","author":"Sultan","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-18","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc10-0493","article-title":"Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study","author":"Massin","year":"2010","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0301-4738.178142-19","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","article-title":"Long-term outcomes of ranibizumab therapy for diabetic macular edema: The 36-month results from two phase III trials: RISE and RIDE","author":"Brown","year":"2013","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-20","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2010.08.016","article-title":"Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study","author":"Nguyen","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-22","first-page":"2312","article-title":"Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: Three-year randomized trial results","author":"Diabetic","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-23","first-page":"972","article-title":"A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: Report 3","author":"Rajendram","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.178142-24","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ophtha.2012.02.010","article-title":"One-year outcomes of the da Vinci study of VEGF trap-eye in eyes with diabetic macular edema","author":"Do","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-25","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-26","first-page":"1193","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","author":"Diabetic","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.178142-27","first-page":"2182","article-title":"A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema","author":"Diabetic","year":"2009","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-28","doi-asserted-by":"crossref","unstructured":"Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-77.e35.","DOI":"10.1016\/j.ophtha.2010.02.031"},{"key":"key-10.4103\/0301-4738.178142-29","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ophtha.2012.04.030","article-title":"Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema","author":"Campochiaro","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-30","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":", Bandello F, Maturi RK, Augustin AJ, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-31","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.ophtha.2012.08.022","article-title":"Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results","author":"Elmen","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00006982-200603000-00024","article-title":"Semiautomated patterned scanning laser for retinal photocoagulation","author":"Blumenkranz","year":"2006","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.178142-33","first-page":"189","article-title":"Subthreshold diode laser micropulse photocoagulation for treatment of diabetic macular edema","author":"Sivaprasad","year":"2012","journal-title":"Expert Rev"},{"key":"key-10.4103\/0301-4738.178142-34","first-page":"1609","article-title":"Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: Incidence, management and outcome","author":"Mithal","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.178142-35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0301-4738.178142-36","first-page":"1388","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results","author":"Comparison","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-37","first-page":"1399","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: One-year findings from the IVAN randomized trial","author":"IVAN","year":"2012","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-38","doi-asserted-by":"crossref","unstructured":"Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-9, 1449.e1-10.","DOI":"10.1016\/j.ophtha.2008.06.015"},{"key":"key-10.4103\/0301-4738.178142-39","first-page":"e5","article-title":"Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema","author":"Diabetic","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/eye.2011.337","article-title":"New approaches for the treatment of diabetic macular oedema: Recommendations by an expert panel","author":"Bandello","year":"2012","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.178142-41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000354548","article-title":"Contemporary management of diabetic retinopathy in Canada: From guidelines to algorithm guidance","author":"Hooper","year":"2014","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0301-4738.178142-42","unstructured":"International Council of Ophthalmology Guidelines for Diabetic Eye Care. ICO, San Francisco, California. 2014."},{"key":"key-10.4103\/0301-4738.178142-43","doi-asserted-by":"crossref","unstructured":"Mitchell P, Wong TY; Diabetic Macular Edema Treatment Guideline Working Group. Management paradigms for diabetic macular edema. Am J Ophthalmol 2014;157:505-13.e1-8.","DOI":"10.1016\/j.ajo.2013.11.012"},{"key":"key-10.4103\/0301-4738.178142-44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/IAE.0b013e3181a2c07a","article-title":"Effect of focal\/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema","author":"Scott","year":"2009","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.178142-45","doi-asserted-by":"crossref","unstructured":"Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H, Apte RS, Beck RR, Bressler NM, et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 2010;117:1087-93.e3.","DOI":"10.1016\/j.ophtha.2009.10.040"},{"key":"key-10.4103\/0301-4738.178142-46","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/IAE.0b013e3181e7974f","article-title":"Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: Diabetic retinopathy clinical research network","author":"Flaxel","year":"2010","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.178142-47","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","author":"Joussen","year":"2004","journal-title":"FASEB J"},{"key":"key-10.4103\/0301-4738.178142-48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","author":"Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/0301-4738.178142-49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1183\/09031936.06.00125404","article-title":"Corticosteroid effects on cell signalling","author":"Barnes","year":"2006","journal-title":"Eur Respir J"},{"key":"key-10.4103\/0301-4738.178142-50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","author":"Nauck","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0301-4738.178142-51","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ophtha.2010.02.032","article-title":"A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact","author":"Gupta","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.178142-52","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/archopht.126.12.1748","article-title":"Resource use and costs associated with diabetic macular edema in elderly persons","author":"Shea","year":"2008","journal-title":"Arch Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:25:07Z","timestamp":1786713907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.178142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["178142"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.178142","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}